Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis.
Michael MegalyMatthew GlogozaIosif XenogiannisEvangelia VemmouIlias NikolakopoulosLaura WillsonDavid J MonyakPatsa SullivanLarissa StanberryPaul SorajjaIvan ChavezMichael MooneyJay TraverseYale WangSantiago A GarciaAnil PouloseMartin Nicholas BurkeEmmanouil S BrilakisPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
VBT can improve the treatment of recurrent DES-ISR, but TLF occurs in approximately one in three patients at 2 years. Initial presentation with ACS was associated with higher TLF and the use of IVUS with a trend for lower incidence of TLF.